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Abstract
Natural killer T (NKT) cells represent an important regulatory T cell subset that develops in the thymus and contains
immature (NK1.1lo) and mature (NK1.1hi) cell subsets. Here we show in mice that an inherited mutation in heterogeneous
ribonucleoprotein L-like protein (hnRNPLLthunder), that shortens the survival of conventional T cells, has no discernible effect
on NKT cell development, homeostasis or effector function. Thus, Hnrpll deficiency effectively increases the NKT:T cell ratio
in the periphery. However, Hnrpll mutation disrupts CD45RA, RB and RC exon silencing of the Ptprc mRNA in both NKT and
conventional T cells, and leads to a comparably dramatic shift to high molecular weight CD45 isoforms. In addition, Hnrpll
mutation has a cell intrinsic effect on the expression of the developmentally regulated cell surface marker NK1.1 on NKT
cells in the thymus and periphery but does not affect cell numbers. Therefore our results highlight both overlapping and
divergent roles for hnRNPLL between conventional T cells and NKT cells. In both cell subsets it is required as a trans-acting
factor to regulate alternative splicing of the Ptprc mRNA, but it is only required for survival of conventional T cells.
Citation: Yabas M, Godfrey DI, Goodnow CC, Hoyne GF (2011) Differential Requirement for the CD45 Splicing Regulator hnRNPLL for Accumulation of NKT and
Conventional T Cells. PLoS ONE 6(11): e26440. doi:10.1371/journal.pone.0026440
Editor: Jacques Zimmer, Centre de Recherche Public de la Sante´ (CRP-Sante´), Luxembourg
Received September 15, 2011; Accepted September 27, 2011; Published November 4, 2011
Copyright: ! 2011 Yabas et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the National Institutes of Health (NIH) contract BAA NIAID-DAIT-07-35; Juvenile Diabetes Research Foundation/National
Health and Medical Research Council (JDRF/NHMRC) Special Program Grant 219167 and JDRF Program Grant 7-2006-327. Dr. Yabas was supported by a
postgraduate award from the Ministry of National Education, Republic of Turkey, Dr. Godfrey by an NHMRC Principal Research Fellowship and Dr. Goodnow by an
Australian Research Council (ARC) Federation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation
of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Chris.Goodnow@anu.edu.au (CG); Gerard.Hoyne@nd.edu.au (GH)
. These authors contributed equally to this work.
¤ Current address: School of Health Sciences, University of Notre Dame Australia, Fremantle, Australia
Introduction
Natural Killer T (NKT) cells are a specialized subset of T
lymphocytes that have the ability to regulate the immune response
in a range of diseases [1,2]. Unlike conventional T cells, NKT cells
express an invariant T-cell receptor a chain (Va14Ja18 in mice
and Va24Ja18 in humans) that is paired with a limited repertoire
of Vb chains (Vb8.2, Vb7, and Vb2 in mice and Vb11 in humans)
[2,3]. The antigen receptor of NKT cells recognizes glycolipid
antigens, such as a-galactosylceramide (a-GalCer), presented by
the nonclassical MHC-I like molecule CD1d [2,4,5]. NKT cells
are positively selected from CD4+ CD8+ double positive (DP)
thymocytes in a CD1d dependent manner in the thymus [6] and
pass through four developmental stages that can be distinguished
on the basis of CD24, CD44 and NK1.1 expression [2,3]. The
most immature cells are CD24+ but lack expression of CD44 and
NK1.1 (stage 0) [7], and these give rise to CD242 cells that are
CD44lo and NK1.1lo (stage 1). These differentiate to become
CD44hi NK1.1lo cells (stage 2) at which point they can be either
exported to the periphery or continue to mature in the thymus
[8,9]. The final stage of maturation coincides with up-regulation of
NK1.1 to become CD44hi NK1.1hi (stage 3) cells [8,9]. The
development and the maintenance of stable numbers of mature
NKT cells in the thymus and periphery is determined by a wide
range of factors including transcription factors (e.g. c-Myc, Egr2,
PLZF, T-Bet) and cytokine signaling via IL-15 and TGF-b [2,3].
The development and function of NKT cells can also be
influenced by costimulatory molecules such as SLAM/SAP,
CD80/CD86 and ICOS [2,3]. Another important feature of
NKT cells is that upon activation they are able to rapidly produce
a diverse range of cytokines and this gives rise to an array of
functionally distinct NKT cell subsets in both mice and humans
that can be distinguished on the basis of the patterns of cytokine
secretion [10,11,12]. Because NKT cell numbers are critical to the
outcome of many diseases [1], and that the numbers vary widely
between individuals [3], it is crucial that we understand how the
development and function of NKT cells differs from that of other
T cell subsets.
The heterogeneous nuclear ribonucleoprotein L-Like,
hnRNPLL, is a member of hnRNP protein family that is essential
for mRNA alternative splicing in T cells [13,14,15]. The role of
hnRNPLL was revealed by a recessive loss of function mouse
mutation isolated in an N-ethyl-N-nitrosourea (ENU) mutagenesis
screen, thunder (Hnrpllthu/thu) [15]. This mutation disrupts the first
of three RNA-recognition motif domains in the hnRNPLL protein
that binds to activation-responsive silencing (ARS) elements in the
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variably expressed exons 4, 5 and 6 of Ptprc [16,17]. As a result,
there is a failure to silence the inclusion of these exons in naı¨ve and
memory T cells so that cell surface CD45 protein shifts from the
normal isoforms on T cells, CD45RB and RO, to forms such as
CD45RA and CD45RC that are normally not found on T cells
[15]. The Hnrpllthu mutation does not affect conventional ab T cell
differentiation in the thymus but it greatly shortens the survival of
naı¨ve and memory ab T cells in the peripheral lymphoid tissues
[15]. This is independent of the change CD45/Ptprc splicing, and
must be explained by alternative splicing among the hundreds of
other mRNAs that are regulated directly or indirectly by Hnrpll
[15,18]. NKT cells express the tyrosine phosphatase CD45, similar
to conventional ab T cells which can express up to eight different
isoforms at the cell surface due to mRNA alternative splicing of
three variable exons on the Ptprc mRNA [19]. The expression of
the CD45 isoforms on conventional T cells is regulated in a
development- and activation-dependent manner that is regulated
by exon silencing by Hnrpll [13,14,15]. Here we examine the
requirement for Hnrpll in NKT cells and show that although
hnRNPLL is required for the splicing of CD45 isoforms in both ab
T cells and NKT cell lineages it does not affect NKT cell
accumulation and survival, although it appears to play a role in
maintaining basal expression of the differentiation marker NK1.1.
Our studies highlight a fundamental difference between the action
of hnRNPLL in conventional T cells and NKT cells.
Results
hnRNPLL is required for the splicing of CD45 isoforms in
NKT cells
Flow cytometric analysis of CD45 isoform expression on NKT
cells was performed by staining thymus and spleen cells from wild
type and Hnrpllthu/thu mice with a -GalCer-loaded CD1d
tetramers and antibodies to TCRb [20,21]. This revealed that
that there was high expression of CD45 and no difference in total
CD45 staining intensity at the cell surface in Hnrpll-mutant NKT
cells (Figure 1A). NKT cells from wild type mice expressed very
little CD45RA or RC isoforms, which include the variable
segments encoded in Ptprc exons 4 and 6 respectively, and
intermediate levels of the CD45RB isoform derived from exon 5.
This pattern of CD45 isoform expression is similar to that
observed on conventional ab T cells (CD4 cells in Figure 1B). By
contrast, CD45RA, CD45RB and CD45RC isoforms were
increased to between 10 and 100 times higher levels on NKT
cells from Hnrpllthu/thu mice (Figure 1B). This result demonstrates
that hnRNPLL is critical for silencing Ptprc exons 4, 5 and 6 within
NKT cells, and Hnrpll mutation has a comparable effect on this
process in NKT and conventional T cells.
Normal NKT cell numbers in the thymus and periphery of
Hnrpllthu/thu mice
Given that NKT cells and conventional T cells develop in the
thymus from the same precursor, we wanted to examine if the
Hnrpll mutation affected NKT cell development, function and
homeostasis. We stained the thymus, spleen and liver of wild type
and Hnrpllthu/thu mice for conventional and NKT cells. Conven-
tional T cells in the thymus were not significantly different in
frequency or absolute number between wild type and Hnrpllthu/thu
mice, but the mutation reduced the number of peripheral CD4+
and CD8+ T cells (Figure 2A) which we have previously shown is
caused by loss of naive CD4+ and CD8+ cells [15]. By comparison,
Hnrpll mutation did not affect the number of NKT cells in the
thymus, spleen or liver (Figure 2B&C). However, we observed that
NKT cells from Hnrpllthu/thu mice have a reproducibly lower level
of TCRb expression as measured by intensity of tetramer staining
compared to wild type cells. Thus, in the spleen the ratio of
absolute number of NKT cells to absolute number of TCRb+
conventional T cells was significantly increased in Hnrpllthu/thu
mice suggesting an important role for hnRNPLL in maintaining a
normal NKT:T cell ratio in the periphery (Figure 2D). Two
subsets of NKT cells can be distinguished based on CD4
expression, namely CD4+ and CD42 [3]. There was no significant
difference in the number of CD4+ or CD42 NKT cell subsets
between wild type and Hnrpllthu/thu mice in the thymus, spleen or
liver (Figure 2E&F). Thus, while NKT and conventional T cells
share a requirement of hnRNPLL to control their CD45 isoforms,
they differ in their hnRNPLL requirement for accumulating in
normal numbers.
Decreased NK1.1 during NKT cell development in
Hnrpllthu/thu mice
NKT cells differentiate in the thymus and progress through
well-defined stages that can be distinguished on the basis of
expression of CD44 and NK1.1 [3]. We examined the
developmental stages of NKT differentiation in the thymus and
peripheral tissues of wild type and Hnrpllthu/thu mice and observed
a slight increase in the mean frequency and absolute number of
CD44lo NK1.1lo (Stage 1) and CD44hi NK1.1lo (Stage 2) NKT
cells and a reduction in the mean frequency and number of
mature CD44hi NK1.1hi (Stage 3) NKT cells in the thymus of
Hnrpllthu/thu mice compared to wild type controls (Figure 3A&B).
Stage 2 NKT cells can undergo maturation to stage 3 cells
either in thymus or peripheral tissues. We also observed a similar
trend with an increase in NK1.12 NKT cells in the spleen of
Hnrpllthu/thu mice with a corresponding reduction of NK1.1+ NKT
cells compared to wild type animals (Figure 3C&D). However the
change in cell numbers within the different cell subsets was not
statistically significant, and rather than representing a defect in
NKT cell maturation, they may simply be secondary to the fact
that Hnrpllthu/thu NKT cells in the thymus and spleen had
significantly lower NK1.1 expression (Figure 3E&F). NK cells in
Hnrpllthu/thu mice also displayed a lower cell surface NK1.1
expression but, similar to the NKT cell population, no difference
in the accumulation of these cells in the peripheral lymphoid
tissues compared to conventional ab T cells was detected
(Figure 3G&H).
The positive selection of NKT cells occurs in a CD1d-
dependent manner from DP thymocytes [6]. Analysis of CD1d
expression in the thymus showed that the Hnrpll mutation does not
affect the expression of CD1d on DP cells (Figure 3I). T-Bet
(Tbx21) is another important factor in the transition from Stage 2
to Stage 3 cells by up-regulating CD122 expression [22].
Intracellular flow cytometric staining of thymic NKT cells
revealed normal T-Bet expression in Hnrpllthu/thu NKT cells
compared to wild type cells (Figure 3J). These results support the
notion that hnRNPLL is not required for the development of
NKT lineage in the thymus or periphery but is required for full
induction of NK1.1.
Hnrpll mutant NKT cells exhibit a cell autonomous
decrease in NK1.1 in mixed bone marrow chimeras
To investigate the possibility that homeostatic effects were
masking a role for hnRNPLL in NKT cell development, mixed
bone marrow chimeras (BMC) were used to investigate the
importance of hnRNPLL on NKT and T cell development in a
competitive situation. Irradiated C57BL/6 mice were reconstitut-
ed with an equal mixture of CD45.1-marked wild-type Hnrpll+/+
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C57BL/6 bone marrow and CD45.2 Hnrpllthu/thu C57BL/6 bone
marrow cells. Recipient mice were analysed 12–14 weeks after
injection by examining donor derived B cells, conventional T and
NKT cells. The relative reconstitution of each chimeric mouse by
Hnrpllthu/thu CD45.2+ hemopoietic stem cells was gauged by the
percentage of B cells that were CD45.2+, since this lineage
Figure 2. Normal numbers of NKT cell in the thymus and periphery of Hnrpllthu/thu mice despite of reduced number of conventional
T cells in the periphery. (A) Graphs show absolute number of CD4 and CD8 conventional T cells in wild type (+/+) and Hnrpllthu/thu (thu/thu) mice
(n = 9 for wild type and n= 8 for Hnrpllthu/thu analysed in two independent experiments). Bars represent the mean 6 s.d. values. (B) Representative
flow cytometric dot plots of NKT cells (a-GalCer-loaded CD1d tetramer+ TCRb+) in the thymus (Thy) and spleen (Spl) in wild type (+/+) and Hnrpllthu/thu
(thu/thu) mice. (C) Graph shows absolute number of NKT cells in the different tissues of wild type (+/+) and Hnrpllthu/thu (thu/thu) mice (n = 12 for wild
type and n= 11 for Hnrpllthu/thu analysed in three independent experiments). Bars represent the mean 6 s.d. values. (D) Graph shows the ratio of
absolute number of NKT cells to absolute number of TCRb+ conventional T cells (n = 12 for wild type (+/+) and n= 11 for Hnrpllthu/thu (thu/thu)
analysed in three independent experiments). Bars represent the mean 6 s.d. values. (E) Representative flow cytometric dot plots comparing the
expression of CD4 versus TCRb on CD1d-tetramer+ TCRb+ NKT cells in the thymus, and spleen of wild type (+/+) and Hnrpllthu/thu (thu/thu) mice.
(F) Graph shows absolute number of CD4+ and CD42 NKT cell subsets in the thymus, spleen and liver of individual wild type (+/+) and Hnrpllthu/thu
(thu/thu) mice (n = 9 for wild type and n=8 for Hnrpllthu/thu analysed in two independent experiments). Bars represent the mean 6 s.d. values.
doi:10.1371/journal.pone.0026440.g002
Figure 1. hnRNPLL is required for the splicing of CD45 isoforms in NKT cells. Representative overlay histograms of (A) CD45 and (B)
CD45RA, CD45RB and CD45RC expressions on wild type (+/+) (shaded grey) and Hnrpllthu/thu (thu/thu) (black line) CD4 T cells and NKT cells in the
thymus (Data are representative of two independent experiments with n = 2–3 mice per group in each).
doi:10.1371/journal.pone.0026440.g001
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expresses very little Hnrpll and is not affected by the Hnrpll
mutation [15]. The results showed that comparing the ratio of T
cells to B cells in the recipient mice, there was a significant
decrease in the proportion of conventional T cells in the spleen
compared to wild type animals (Figure 4A). The competitive
disadvantage of Hnrpllthu/thu derived conventional TCRab+ cells
in the periphery is consistent with previous studies in mixed
chimeras [15]. In contrast there was no significant difference in the
ratio of wild type or Hnrpllthu/thu derived NKT cells to B cells in
the spleen of recipient mice (Figure 4B), establishing that the loss of
function of hnRNPLL did not affect the differentiation or long-term
survival of mature NKT cells. Detailed analysis of Hnrpllthu/thu versus
Figure 3. Decreased NK1.1 during NKT cell development in Hnrpllthu/thu mice. (A, C) Representative flow cytometric dot plots showing the
development stages of NKT cell in the (a) thymus and (c) spleen in intact wild type (+/+) and Hnrpllthu/thu (thu/thu) mice based on expression of CD44
and NK1.1 that were gated on a-Galcer-Cd1d tetramer+ TCRb+ NKT cells. (B, D) Graphs show the absolute number of the three development stages of
NKT cell in the (b) thymus and (d) spleen and liver respectively (n = 9 for wild type and n= 8 for Hnrpllthu/thu analysed in two independent
experiments). Bars represent the mean 6 s.d. values. (E, F) Graphs show the geometric mean florescence intensity (MFI) of NK1.1 in the thymic and
splenic NKT cells respectively (Data are representative of three independent experiments with n = 3–5 mice per group in each). Bars represent the
mean 6 s.d. values. (G) Graph shows the absolute number of NK1.1+ TCRb2 NK cell in the spleen (Data are representative of three independent
experiments with n = 3–5 mice per group in each). Bars represent the mean 6 s.d. values. (H) Graph shows the geometric mean florescence intensity
(MFI) of NK1.1 in the splenic NK cells (Data are representative of three independent experiments with n = 3–5 mice per group in each). Bars represent
the mean 6 s.d. values. (I) Representative overlay histograms comparing the expression of CD1d on DP thymocytes and B220+ cells in the spleen.
(J) Representative overlay histograms showing the intracellular expression of T-Bet in NKT cells from the thymus of a wild type (dotted line) and
Hnrpllthu/thu mouse (solid line) (Data are representative of two independent experiments with n= 3–5 mice per group in each).
doi:10.1371/journal.pone.0026440.g003
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wild-type NKT cells in the mixed chimeras revealed that, consistent
with the results shown above, themean fluorescence intensity of NK1.1
expression was significantly lower onHnrpllthu/thu derived NKT cells in
the thymus (Figure 4C) and spleen (Figure 4D). Taken together, these
data show that hnRNPLL is not required for the development or
persistence of NKT cells in the immune system, in contrast to its role in
conventional T cells, but it functions cell intrinsically to regulate NK1.1
expression in NKT cells.
Mature NKT cells in Hnrpllthu/thu mice can survive
normally in the presence of IL-15
The maturation of NKT cells from the NK1.1lo to NK1.1hi
stage coincides with expression of the CD122 that confers
responsiveness to IL-15 and leads to increased expression of
NK1.1 and their long term survival in vivo [23,24]. Based on our
hypothesis that hnRNPLL is required to regulate NK1.1
expression but does not influence NKT cell maturation, a
prediction is that the Hnrpllthu/thu NKT cells should show
comparable expression of CD122 and survival in the presence of
IL-15 compared to wild type cells. Indeed, the Hnrpll mutation did
not affect the expression of CD122 as determined by flow cytom-
etric staining of NKT cells between wild type and Hnrpllthu/thu
mutant cells (Figure 5A–C). Next we examined the survival of wild
type and Hnrpllthu/thu thymic NKT cells in the presence or absence
of IL-15 for 3 days. The viability of the cells was analysed by staining
with 7-AAD and quantitated by flow cytometry. We found no
difference in the survival between wild type or Hnrpllthu/thu NKT
cells to IL-15 in vitro at each concentration of IL-15 tested
(Figure 5D).
Hnrpll mutation does not disrupt cytokine by NKT cells
Immature and mature NKT cells are able to rapidly secrete
cytokines following activation [2,25]. We examined the cytokine
production by wild type and Hnrpllthu/thu NKT cells following
short-term activation of freshly isolated cells in the thymus, spleen
and liver. NKT cells were stimulated in vitro in the presence of
PMA and ionomycin for 3–4 h and intracellular cytokine analysis
was examined for IFN-c, IL-4, TNF, IL-17 and IL-2 (Figure 6).
There was little or no difference in the patterns of IFN-c, IL-4,
TNF, IL-17 and IL-2 secretion between the Hnrpllthu/thu and wild
type thymic NKT cells (Figure 6A&B). In addition wild type and
Hnrpllthu/thu derived NKT cells secreted comparable levels of IFN-
c, IL-4, TNF, IL-17 and IL-2 in the spleen and liver
(Figure 6C&D). Overall the results indicate that the Hnrpll
mutation does not affect cytokine production by in vitro activated
NKT cells.
Figure 4. Normal contribution of Hnrpllthu/thu NKT cells, but a cell autonomous decrease in NK1.1 in the mixed bone marrow
chimeras. Irradiated C57BL/6 mice were reconstituted with an equal mixture of CD45.1-marked wild-type bone marrow and CD45.2-marked
Hnrpllthu/thu bone marrow cells. After hemopoietic reconstitution, recipient mice were analysed for B, NKT and conventional T cell populations.
(A) Graph shows the ratio of CD45.2+ wild type and Hnrpllthu/thu derived T cells to CD45.2+ wild type and Hnrpllthu/thu derived B cells in the spleen of
chimeric recipient mice. (B) Graph shows the ratio of CD45.2+ wild type and Hnrpllthu/thu derived NKT cells to CD45.2+ wild type and Hnrpllthu/thu
derived B cells in the spleen of chimeric recipient mice. (C, D) Representative overlay histograms comparing the expression of NK1.1 on wild type
(shaded grey) and Hnrpllthu/thu (black line) derived NKT cells in the (b) thymus and (c) spleen of individual recipient mice from mixed bone marrow
chimeras. Graphs show the geometric mean florescence intensity (MFI) of NK1.1 in the CD45.2+ wild type or Hnrpllthu/thu derived NKT cells in the
(b) thymus and (c) spleen of individual recipient mice from mixed bone marrow chimeras. (n = 6 for wild type and n= 5 for Hnrpllthu/thu). Bars
represent the mean 6 s.d. values.
doi:10.1371/journal.pone.0026440.g004
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Discussion
hnRNPLL has previously been shown to control the survival of
naive CD4+ and CD8+ conventional T cells in the peripheral
circulation [15]. In this report we show that hnRNPLL is required
for exon silencing of the variable exons of the Ptprc nascent mRNA
in NKT cells and this function is conserved across multiple cell
lineages in the immune system [15]. In contrast to conventional
CD4+ and CD8+ TCR ab+ cells we did not observe any effect of
the hnRNPLLthu/thu allele on NKT cell development, effector cell
responses or the maintenance of stable NKT cell numbers in the
lymphoid and non-lymphoid tissues. However, Hnrpllthu/thu
derived NKT and NK cells displayed lower expression of the
developmental marker NK1.1 that appears to be independent of
IL-15 and TCR signaling. This study reveals a divergent role for
hnRNPLL within different T cell lineages, which presumably
reflects a difference in their dependence on alternative mRNA
splicing.
The NK1.1lo to NK1.1hi transition represents an important
developmental checkpoint in NKT cell maturation that relies on both
TCR and IL-15 signaling [23,24,26,27], but the homeostatic
proliferation and maintenance of mature NK1.1+ cells in the immune
system is independent of TCR-CD1d signaling and relies instead on
the availability of IL-15 and signaling through the IL-15R on NKT
cells [24]. Importantly NKT cells are not the only cells in the immune
system that rely on IL-15 for their homeostasis, memory CD8+CD44hi
T cells and NK cells proliferate strongly in response to IL-15 [11,28].
CD45 is an abundant tyrosine phosphatase expressed by
leukocytes and undergoes alternative splicing of the three variable
exons 4, 5 and 6 to yield multiple isoforms. The two related
proteins hnRNPL and hnRNPLL function as trans acting factors
that regulate exon silencing of the variable exons of Ptprc mRNA in
CD4+ and CD8+ T cells [13,14,15,17,29]. As shown here wild
type NKT cells normally express only low levels of the high
molecular weight CD45 isoforms CD45RA and CD45RC at the
cell surface as they rely on a functional hnRNPLL to mediate the
exon silencing of Ptprc mRNA of the three variable exons. The
Hnrpll mutation disrupts binding to ARS sequences found in Ptprc
exons 4–6, leads to inclusion of these exons and a dramatic shift to
CD45RA+, RB+ and RC+ isoforms in NKT cells. Despite the
inappropriate expression of the high molecular CD45 isoforms,
this did not affect NKT cell development or effector responses
following activation. This is similar to our recent observation that
constitutive expression of CD45 isoforms in conventional T cells of
hnRNPLL mutant mice was also not responsible for the disruption
to T cell homeostasis observed in these mice [18].
The mechanism responsible for the lower NK1.1 expression in
Hnrpllthu/thu NKT cells is unclear, but our data would suggest that
it is independent of T-Bet and CD122 as the expression of both
proteins was comparable between wild type and mutant cells. A
focus of future studies would be to identify the specific cis- or trans
acting factor(s) that directs NK1.1 gene expression, to identify if
they are targets of mRNA splicing controlled by hnRNPLL. The
biological significance of NK1.1 expression itself by NKT cells is
Figure 5. The Hnrpllmutation does not affect the up-regulation of CD122 in the developmental stages of NKT cell. (A) Representative
overlay histograms showing the expression of CD122 on the surface of NKT cells from the thymus of a wild type and Hnrpllthu/thu mouse.
(B) Representative overlay histograms comparing CD122 expression on stage 1 (CD44lo NK1.1lo), stage 2 (CD44hi NK1.1lo) and stage 3 (CD44hi NK1.1hi)
NKT cells in the thymus in wild type (left) and Hnrpllthu/thu mice (right). (C) Graph shows the geometric mean fluorescence intensity (MFI) of CD122
expression on stage 2 and 3 NKT cells and DP thymocytes in the thymus and NKT cells and TCRb+ cells in the spleen. Bars represent the mean value of
each group 6 s.d. from one of two independent experiments with a group of n= 3–5 mice per group in each. (D) In vitro survival of NKT cells culture
in the presence of varying concentrations of IL-15. Data shows the percentage of viable cells by 7-AAD exclusion after 3 days of culture for wild type
(+/+) and Hnrpllthu/thu (thu/thu) thymic NKT cells. Graph from one of three independent experiments represents the average of viable cells recovered
from duplicate cultures with 2 or 3 mice per group.
doi:10.1371/journal.pone.0026440.g005
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unclear. A population of mature NK1.12 NKT cells exists in the
periphery of normal mice and these cells are capable of producing
similar amounts of cytokines to their NK1.1+ counterparts [30].
However, antibody mediated NK1.1 cross-linking is capable of
activating NKT cells to produce IFN-c [31] and NK1.1 expression
levels transiently decrease following TCR mediated NKT cell
activation [32,33]. The human counterpart of this molecule
(CD161c) is also a known maturation marker for human NKT
cells [3], but again, the functional significance of this molecule in
humans is unknown. Thus, whether the NK1.1 cell surface
receptor is important for the function of NKT cells remains an
interesting question that needs to be resolved.
In conclusion, our studies have demonstrated that hnRNPLL is
necessary for CD45 alternative splicing in both conventional T
and NKT cells. The studies presented here also reinforce that we
still have a lot to learn about mRNA splicing in the immune
system. In naive conventional T cells it controls their long-term
survival and homeostasis, but in NKT cells it does not affect
lineage development or effector cell differentiation but has an
effect on regulation of an important developmental marker
NK1.1.
Materials and Methods
Mice
The Hnrpllthu/thu mouse strain has been previously described
and was generated and maintained on a C57BL/6 background
[15]. The C57BL/6 (B6) inbred mouse strain was originally
obtained from Stanford University. All mice were housed and
maintained in specific pathogen free conditions at the Australian
Phenomics Facility and all animal procedures were approved by
the Australian National University Animal Ethics and Experi-
mentation Committee. The following is the ethics number
approval for the proposal at the time: Proposal Nos: J.IG.31.04.
Cell Preparation and Flow Cytometry
Single cell suspensions from thymus, spleen and liver were
labelled with mixtures made of the following antibodies: PE
Figure 6. The Hnrpll mutation does not disrupt cytokine production by thymic, splenic and hepatic NKT cells. (A) Representative
histograms showing intracellular cytokine production by a-GalCer-CD1d tetramer+ TCRb+ NKT cells from wild type (+/+) and Hnrpllthu/thu (thu/thu)
mice that were either resting (shaded grey) or following activation with PMA and ionomycin (black line). (B) Frequency of cytokine producing cells of
total NKT cells in the thymus of wild type and Hnrpllthu/thu mice. (C) Frequency of cytokine producing cells of total NKT cells in the spleen of wild type
and Hnrpllthu/thu mice. (D) Frequency of cytokine producing cells of total NKT cells in the liver of wild type and Hnrpllthu/thu mice. Bars represent the
mean value of each group 6 s.d. from one of two independent experiments with a group of n= 3–5 mice per group in each.
doi:10.1371/journal.pone.0026440.g006
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labelled CD1d tetramer loaded with a-galactosylceramide (Sap-
phire Bioscience) was produced in house using a construct
provided by M. Kronenberg (La Jolla Institute for Allergy and
Immunology, San Diego, CA), FITC labelled anti-TCRb (clone
H57-597) from BD Pharmingen or APC-Cy7 labelled anti-TCRb
(clone H57-597) from Biolegend, APC, FITC or PE-Cy7 labelled
anti-NK1.1 (clone PK136) from BD Pharmingen, Alexa Flour 700
labelled anti-CD4 (clone RM4-5) or APC-Cy7 labelled anti-CD4
(clone GK1.5) from BD Pharmingen, PE-Cy7 labelled anti-CD8
(clone 53-6.7) from Biolegend, Pacific Blue labelled anti-CD44
(clone IM7) from Biolegend, Alexa Flour 700 labelled anti-CD45.1
(clone A20) from Biolegend, PerCP-Cy5.5 labelled anti-CD45.2
(clone 104) from BD Pharmingen, FITC labelled anti-CD45 (clone
30-F11) from BD Pharmingen, PerCP-Cy5.5 labelled anti-mouse/
human T-Bet (clone eBio4B10) from eBioscience, FITC labelled
rat anti-mouse CD122 from BD Pharmingen, PerCP labelled anti-
CD45R/B220 (clone RA3-6B2) from BD Pharmingen, Biotin
anti-CD45RA (clone 14.8) from BD Pharmingen, FITC labelled
anti-CD45RB (clone 16A) from BD Pharmingen, PE labelled anti-
CD45RC (clone DNL-1.9) from BD Pharmingen, Qdot 605
streptavidin conjugate from Invitrogen, PE labelled anti-CD1d
(clone 1B1) from BD Pharmingen.
Cell suspensions were incubated with appropriate mixture of
antibodies at 4uC at the dark for 30 mins. Cells then washed with
flow cytometry buffer containing 2% Bovine Serum and 0.1%
NaN3 in PBS. Flow cytometry was performed on a LSR II (BD
Biosciences) and analysed using FlowJo (Tree Star) software.
Generation of Bone Marrow Chimeras
Bone marrow chimeric mice were generated by the injection of
C57BL/6 (CD45.1 or CD45.2) and Hnrpllthu/thu (CD45.2) donor
bone marrow cells into irradiated C57BL/6 (CD45.1) recipients.
The irradiation dose was 26450 rad and mixed at a 1:1 ratio of
donor cells injected intravenously at a 200 mL/mouse into the tail
veins of recipients. Mice were sacrificed 12–14 weeks after the
transplantation for ex vivo analysis of the immune system.
Survival assay
Thymic NKT cells were cultured in vitro in the presence or
absence of IL-15 (R&D Systems) for 3 days at 37uC and 5% CO2.
The cells were harvested from the plate and stained with antibodies
to cell surface markers and 7-aminoactiomycin (7-AAD) (Invitrogen)
and the cell viability was analysed by flow cytometry as described
above.
Cell culture and intracellular cytokine staining
For in vitro stimulation assay, single cell suspensions were made
from thymus, spleen and liver and cells were cultured in RPMI
1640 medium (Gibco) supplemented with penicillin, streptomycin,
Glutamax, 1 mM sodium pyruvate (Sigma Aldrich), 0.1 mM
nonessential amino acids (Sigma Aldrich), 10 mM Hepes (Sigma
Aldrich), 55 mM 2-ME (Gibco) and 10% FCS in a 24-well plate in
the presence or absence of 50 ng/ml PMA (Sigma), 500 ng/ml
ionomycin (Sigma), and Golgi Stop (BD Pharmingen) for 3–4 h at
37uC and 5% CO2. After culture, surface markers were stained as
detailed above prior to fixation of the cells. Cells were washed and
stained intracellularly with FITC labelled anti-IL-4 (clone 11B11)
from BD Pharmingen, Alexa Flour 700 labelled anti-IL-2 (clone
JES6-5H4) from Biolegend, APC labelled anti-TNF (clone MP6-
XT22) from eBioscience, Alexa Flour 700 labelled anti-IL-17A
(clone TC11-18H10.1) from Biolegend and APC labelled anti-
IFN-c (clone XMG1.2) using the eBioscence Fixation/Permeabi-
lization kit according to the manufacturer’s instructions. Flow
cytometry analysis of samples was performed on a LSR II (BD
Biosciences) and analysed using FlowJo (Tree Star) software.
Statistical analyses
Statistical analysis was performed with the Mann-Whitney
Rank-Sum U-test using GraphPad Prism software.
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